Chronic liver disease (CLD) is a continuous process that causes a reduction of liver function
lasting more than six months. CLD includes alcoholic liver disease (ALD), non-alcoholic fatty …

The number of diabetic patients has risen dramatically in recent decades, owing mostly to
the rising incidence of type 2 diabetes mellitus (T2DM). Several oral antidiabetic …

Ulcerative colitis (UC) is a chronic relapsing inflammatory disease of the colorectal area that
demonstrates a dramatically increasing incidence worldwide. This study provides novel …

Highlights•Discovery of new drugs against cancer is of utmost importance.•Drug repurposing
is an alternative approach to traditional drug discovery.•It significantly reduces the R&D …

Simple Summary The study investigates the potential use of metformin, a medication
commonly prescribed for type 2 diabetes, in the treatment of hepatocellular carcinoma …

Hepatocellular carcinoma (HCC) is the third foremost cause of cancer-related deaths. HCC
has a very bad prognosis because it is asymptomatic in the early stages, resulting in a late …

Sorafenib, a multikinase inhibitor, is a first-line treatment for advanced hepatocellular
carcinoma, but its long-term effectiveness is limited by the emergence of resistance …

Ulcerative colitis is an idiopathic disease that is widely incident worldwide. Canagliflozin,
antidiabetic agent, exhibited significant anti-inflammatory effects in a variety of animal …

Abstract Aims The hsa-miR-128-3p expression is downregulated in advanced breast cancer
patients. Empagliflozin (EMPA) is an anti-diabetic drug with anticancer potential. The …

Ulcerative colitis (UC), an inflammatory bowel disease, is a chronic condition of a
multifaceted pathophysiology. The incidence of UC is increasing internationally. The current …